<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34442710</PMID><DateRevised><Year>2021</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>30</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Sars-CoV-2 Virus Infection May Interfere CD34+ Hematopoietic Stem Cells and Megakaryocyte-Erythroid Progenitors Differentiation Contributing to Platelet Defection towards Insurgence of Thrombocytopenia and Thrombophilia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1632</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms9081632</ELocationID><Abstract><AbstractText>To date, several cases of thrombosis have been confirmed to be related to Sars-CoV-2 infection. Multiple attempts detected the prolonged occurrence of Sars-CoV-2 viral RNA (long COVID) in whole blood suggesting that virus byproducts may remain within cells and tissues well over the disease has finished. Patients may develop severe thrombocytopenia, acute anemia of inflammation and, systemic thrombosis with the fatal course of disease, which is suggestive of further interferences of Sars-CoV-2 on hematopoietic stem cells (HSCs) within the differentiation process towards erythroid and megakaryocytic cells. Therefore, we speculated whether Sars-CoV-2 propagates in or compartmentalizes with hematopoietic progenitor, erythroid, and megakaryocytic cells as the main cause of thrombotic events in either COVID-19 patients or vaccinated individuals. Results: The Sars-CoV-2 RNA replication, protein translation and infectious particle formation as the spike proteins in hematopoietic cell lines take place via the angiotensin-converting enzyme 2 (ACE2) entry pathway within primary CD34<sup>+</sup> HSCs inducing, ex vivo, the formation of defected erythroid and megakaryocytic cells that eventually become targets of humoral and adaptive immune cells. Conclusions: Viral particles from affected CD34<sup>+</sup> HSCs or the cellular component of RBC units and eventually platelets, present the greatest risk for sever thrombosis-transmitted Sars-CoV-2 infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Balzanelli</LastName><ForeName>Mario Giosu&#xe8;</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>SET-118, Department of Pre-Hospital and Emergency, SG Giuseppe Moscati Hospital, 74100 Taranto, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Distratis</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>SET-118, Department of Pre-Hospital and Emergency, SG Giuseppe Moscati Hospital, 74100 Taranto, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dipalma</LastName><ForeName>Gianna</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5947-8987</Identifier><AffiliationInfo><Affiliation>Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vimercati</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4072-2871</Identifier><AffiliationInfo><Affiliation>Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inchingolo</LastName><ForeName>Alessio Danilo</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0002-6366-1039</Identifier><AffiliationInfo><Affiliation>Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzaro</LastName><ForeName>Rita</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2670-8811</Identifier><AffiliationInfo><Affiliation>SET-118, Department of Pre-Hospital and Emergency, SG Giuseppe Moscati Hospital, 74100 Taranto, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aityan</LastName><ForeName>Sergey Khachatur</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Director Multidisciplinary Research Center, Lincoln University, Oakland, CA 94612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maggiore</LastName><ForeName>Maria Elena</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancini</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7103-4086</Identifier><AffiliationInfo><Affiliation>Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laforgia</LastName><ForeName>Rita</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3580-4976</Identifier><AffiliationInfo><Affiliation>Department of Emergency and Organ Transplantation, University of Bari "Aldo Moro", 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pezzolla</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency and Organ Transplantation, University of Bari "Aldo Moro", 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomassone</LastName><ForeName>Diego</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5161-5417</Identifier><AffiliationInfo><Affiliation>HOLOS Medical and Research Center, 00071 Pomezia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Foundation of Physics Research Center, 87053 Celico, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Van Hung</ForeName><Initials>VH</Initials><AffiliationInfo><Affiliation>"Phan Chau Trinh" University of Medicine and Nam-Khoa Biotek, Ho Chi Minh 50000, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacobone</LastName><ForeName>Donatello</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>SET-118, Department of Pre-Hospital and Emergency, BAT, 76121 Barletta, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castrignano</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Post Acute COVID-19 Department, "Umberto I" Hospital Unit-PTA, 74017 Mottola, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarano</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1374-6146</Identifier><AffiliationInfo><Affiliation>Department of Innovative Technologies in Medicine and Dentistry, University of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorusso</LastName><ForeName>Felice</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-2660-9231</Identifier><AffiliationInfo><Affiliation>Department of Innovative Technologies in Medicine and Dentistry, University of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tafuri</LastName><ForeName>Silvio</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4194-0210</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Science and Human Oncology, University of Bari, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Migliore</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University Policlinic Hospital of Bari, 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inchingolo</LastName><ForeName>Angelo Michele</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Kieu Cao Diem</ForeName><Initials>KCD</Initials><AffiliationInfo><Affiliation>Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HOLOS Medical and Research Center, 00071 Pomezia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>American Stem Cells Hospital, Ho Chi Minh 70000, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toai</LastName><ForeName>Tran Cong</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Histology-Embryology and Genetic, "Pham Ngoc Thach"-University of Medicine, Ho Chi Minh 70000, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inchingolo</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3797-5883</Identifier><AffiliationInfo><Affiliation>Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isacco</LastName><ForeName>Ciro Gargiulo</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>SET-118, Department of Pre-Hospital and Emergency, SG Giuseppe Moscati Hospital, 74100 Taranto, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HOLOS Medical and Research Center, 00071 Pomezia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Phan Chau Trinh" University of Medicine and Nam-Khoa Biotek, Ho Chi Minh 50000, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>American Stem Cells Hospital, Ho Chi Minh 70000, Vietnam.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD34+ hematopoietic stem cell (HSCs)</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Sars-CoV-2</Keyword><Keyword MajorTopicYN="N">angiotensin-converting enzyme 2 (ACE2)</Keyword><Keyword MajorTopicYN="N">thrombophilia</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>27</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34442710</ArticleId><ArticleId IdType="pmc">PMC8400074</ArticleId><ArticleId IdType="doi">10.3390/microorganisms9081632</ArticleId><ArticleId IdType="pii">microorganisms9081632</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.-L., et al. A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature. 2020;579:270&#x2013;273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W., Tian J.-H., Pei Y.-Y., et al. A New Coronavirus Associated with Human Respiratory Disease in China. Nature. 2020;579:265&#x2013;269. doi: 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratajczak M.Z., Kucia M. SARS-CoV-2 Infection and Overactivation of Nlrp3 Inflammasome as a Trigger of Cytokine &#x201c;Storm&#x201d; and Risk Factor for Damage of Hematopoietic Stem Cells. Leukemia. 2020;34:1726&#x2013;1729. doi: 10.1038/s41375-020-0887-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41375-020-0887-9</ArticleId><ArticleId IdType="pmc">PMC7262681</ArticleId><ArticleId IdType="pubmed">32483300</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantefardo B., Gube A.A., Awlachew E., Sisay G. Novel Coronavirus (COVID-19)-Associated Guillain&#x2013;Barre&#x2019; Syndrome: Case Report. IMCRJ. 2021;14:251&#x2013;253. doi: 10.2147/IMCRJ.S305693.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IMCRJ.S305693</ArticleId><ArticleId IdType="pmc">PMC8068515</ArticleId><ArticleId IdType="pubmed">33907474</ArticleId></ArticleIdList></Reference><Reference><Citation>Caress J.B., Castoro R.J., Simmons Z., Scelsa S.N., Lewis R.A., Ahlawat A., Narayanaswami P. COVID-19-Associated Guillain-Barr&#xe9; Syndrome: The Early Pandemic Experience. Muscle Nerve. 2020;62:485&#x2013;491. doi: 10.1002/mus.27024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27024</ArticleId><ArticleId IdType="pmc">PMC7405390</ArticleId><ArticleId IdType="pubmed">32678460</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Disease (COVID-19) Situation Reports.  [(accessed on 23 July 2021)]; Available online:  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.</Citation></Reference><Reference><Citation>Nur E., Gaartman A.E., Tuijn C.F.J., Tang M.W., Biemond B.J. Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease Due to 2019 Novel Coronavirus Disease (COVID-19) Am. J. Hematol. 2020;95:725&#x2013;726. doi: 10.1002/ajh.25821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25821</ArticleId><ArticleId IdType="pmc">PMC7262303</ArticleId><ArticleId IdType="pubmed">32267016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieber E. Erythropoietin, the Biology of Erythropoiesis and Epoetin Alfa. An Overview. J. Reprod. Med. 2001;46:521&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">11396386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushansky K. The Molecular Mechanisms That Control Thrombopoiesis. J. Clin. Investig. 2005;115:3339&#x2013;3347. doi: 10.1172/JCI26674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI26674</ArticleId><ArticleId IdType="pmc">PMC1297257</ArticleId><ArticleId IdType="pubmed">16322778</ArticleId></ArticleIdList></Reference><Reference><Citation>Luck L., Zeng L., Hiti A.L., Weinberg K.I., Malik P. Human CD34+ and CD34+CD38&#x2212; Hematopoietic Progenitors in Sickle Cell Disease Differ Phenotypically and Functionally from Normal and Suggest Distinct Subpopulations That Generate F Cells. Exp. Hematol. 2004;32:483&#x2013;493. doi: 10.1016/j.exphem.2004.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exphem.2004.02.003</ArticleId><ArticleId IdType="pubmed">15145217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratz-Albers K., Scheding S., M&#xf6;hle R., B&#xfc;hring H.J., Baum C.M., Mc Kearn J.P., B&#xfc;chner T., Kanz L., Brugger W. Effective Ex Vivo Generation of Megakaryocytic Cells from Mobilized Peripheral Blood CD34+ Cells with Stem Cell Factor and Promegapoietin. Exp. Hematol. 2000;28:335&#x2013;346. doi: 10.1016/S0301-472X(99)00152-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-472X(99)00152-6</ArticleId><ArticleId IdType="pubmed">10720698</ArticleId></ArticleIdList></Reference><Reference><Citation>Attar A. Changes in the Cell Surface Markers during Normal Hematopoiesis: A Guide to Cell Isolation. Glob. J. Hematol. Blood Transfus. 2014;1:20&#x2013;28. doi: 10.15379/2408-9877.2014.01.01.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15379/2408-9877.2014.01.01.4</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerga Encabo H., Grey W., Garcia-Albornoz M., Wood H., Ulferts R., Aramburu I.V., Kulasekararaj A.G., Mufti G., Papayannopoulos V., Beale R., et al. Human Erythroid Progenitors Are Directly Infected by SARS-CoV-2: Implications for Emerging Erythropoiesis in Severe COVID-19 Patients. Stem Cell Rep. 2021;16:428&#x2013;436. doi: 10.1016/j.stemcr.2021.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.02.001</ArticleId><ArticleId IdType="pmc">PMC7862909</ArticleId><ArticleId IdType="pubmed">33581053</ArticleId></ArticleIdList></Reference><Reference><Citation>Odak I., Barros-Martins J., Bo&#x161;njak B., Stahl K., David S., Wiesner O., Busch M., Hoeper M.M., Pink I., Welte T., et al. Reappearance of Effector T Cells Is Associated with Recovery from COVID-19. EBioMedicine. 2020;57:102885. doi: 10.1016/j.ebiom.2020.102885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102885</ArticleId><ArticleId IdType="pmc">PMC7338277</ArticleId><ArticleId IdType="pubmed">32650275</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz S., Xu L., Osman M., Sligl W., Shields J., Joyce M., Tyrrell L., Oyegbami O., Elahi S. Erythroid Precursors and Progenitors Suppress Adaptive Immunity and Get Invaded by SARS-CoV-2. Stem Cell Rep. 2021;16:1165&#x2013;1181. doi: 10.1016/j.stemcr.2021.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.04.001</ArticleId><ArticleId IdType="pmc">PMC8111797</ArticleId><ArticleId IdType="pubmed">33979601</ArticleId></ArticleIdList></Reference><Reference><Citation>Balzanelli M., Distratis P., Catucci O., Amatulli F., Cefalo A., Lazzaro R., Aityan K.S., Dalagni G., Nico A., De Michele A., et al. Clinical and Diagnostic Findings in COVID-19 Patients: An Original Research from SG Moscati Hospital in Taranto Italy. J. Biol. Regul. Homeost. Agents. 2021;35:171&#x2013;183. doi: 10.23812/20-605-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-605-A</ArticleId><ArticleId IdType="pubmed">33491346</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavezzi A., Troiani E., Corrao S. COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review. Clin. Pract. 2020;10:24&#x2013;30. doi: 10.4081/cp.2020.1271.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/cp.2020.1271</ArticleId><ArticleId IdType="pmc">PMC7267810</ArticleId><ArticleId IdType="pubmed">32509258</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Castelnuovo A., Costanzo S., Antinori A., Berselli N., Blandi L., Bonaccio M., Cauda R., Guaraldi G., Menicanti L., Mennuni M., et al. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb. Haemost. 2021;121:1054&#x2013;1065. doi: 10.1055/a-1347-6070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1347-6070</ArticleId><ArticleId IdType="pubmed">33412596</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Liu Y., Wang X., Yang L., Li H., Wang Y., Liu M., Zhao X., Xie Y., Yang Y., et al. SARS-CoV-2 Binds Platelet ACE2 to Enhance Thrombosis in COVID-19. J. Hematol. Oncol. 2020;13:120. doi: 10.1186/s13045-020-00954-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType="pmc">PMC7471641</ArticleId><ArticleId IdType="pubmed">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth H., Schneider L., Eberle R., Lausen J., Modlich U., Bl&#xfc;mel J., Baylis S.A. Zika Virus Infection Studies with CD34+ Hematopoietic and Megakaryocyte-Erythroid Progenitors, Red Blood Cells and Platelets. Transfusion. 2020;60:561&#x2013;574. doi: 10.1111/trf.15692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.15692</ArticleId><ArticleId IdType="pubmed">32086956</ArticleId></ArticleIdList></Reference><Reference><Citation>Balzanelli G.M., Distratis P., Amatulli F., Lazzaro R., Cefalo A., Dangela G., Catucci O., Palazzo D., Tomassone D., Pham S.A., et al. Would The End Of COVID-19 Infection As A Chronic Disease? J. Stem Cells Res. Dev. Ther. 2020;6:1&#x2013;3. doi: 10.24966/SRDT-2060/100057.</Citation><ArticleIdList><ArticleId IdType="doi">10.24966/SRDT-2060/100057</ArticleId></ArticleIdList></Reference><Reference><Citation>Balzanelli M.G., Distratis P., Aityan S.K., Amatulli F., Catucci O., Cefalo A., De Michele A., Dipalma G., Inchingolo F., Lazzaro R., et al. An Alternative &#x201c;Trojan Horse&#x201d; Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology. Endocr. Metab. Immune Disord. Drug Targets. 2021;21:1. doi: 10.2174/1871530321666210127141945.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871530321666210127141945</ArticleId><ArticleId IdType="pubmed">33504318</ArticleId></ArticleIdList></Reference><Reference><Citation>Balzanelli G.M., Distratis P., Amatulli F., Catucci O., Cefalo A., Lazzaro R., Palazzo D., Aityan K.S., Dipalma G., Inchingolo F. Clinical Features in Predicting COVID-19. Biomed. J. Sci. Tech. Res. 2020;29:22921&#x2013;22926.</Citation></Reference><Reference><Citation>Greco E., Lupia E., Bosco O., Vizio B., Montrucchio G. Platelets and Multi-Organ Failure in Sepsis. Int. J. Mol. Sci. 2017;18:2200. doi: 10.3390/ijms18102200.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102200</ArticleId><ArticleId IdType="pmc">PMC5666881</ArticleId><ArticleId IdType="pubmed">29053592</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardon-Bounes F., Ruiz S., Gratacap M.-P., Garcia C., Payrastre B., Minville V. Platelets Are Critical Key Players in Sepsis. Int. J. Mol. Sci. 2019;20:3494. doi: 10.3390/ijms20143494.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20143494</ArticleId><ArticleId IdType="pmc">PMC6679237</ArticleId><ArticleId IdType="pubmed">31315248</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballini A., Dipalma G., Isacco C.G., Boccellino M., Di Domenico M., Santacroce L., Nguy&#x1ec5;n K.C.D., Scacco S., Calvani M., Boddi A., et al. Oral Microbiota and Immune System Crosstalk: A Translational Research. Biology. 2020;9:131. doi: 10.3390/biology9060131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology9060131</ArticleId><ArticleId IdType="pmc">PMC7344575</ArticleId><ArticleId IdType="pubmed">32560235</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazzolla A.P., Lovero R., Lo Muzio L., Testa N.F., Schirinzi A., Palmieri G., Pozzessere P., Procacci V., Di Comite M., Ciavarella D. Taste and Smell Disorders in COVID-19 Patients: Role of Interleukin-6. ACS Chem. Neurosci. 2020;11:2774&#x2013;2781. doi: 10.1021/acschemneuro.0c00447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00447</ArticleId><ArticleId IdType="pubmed">32786309</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Florencio L.L. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int. J. Environ. Res. Public Health. 2021;18:2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Nejad J.H., Heiat M., Hosseini M.J., Allahyari F., Lashkari A., Torabi R., Ranjbar R. Guillain-Barr&#xe9; Syndrome Associated with COVID-19: A Case Report Study. J. Neurovirol. 2021 doi: 10.1007/s13365-021-00984-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00984-y</ArticleId><ArticleId IdType="pmc">PMC8158074</ArticleId><ArticleId IdType="pubmed">34046865</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargiulo C., Hai N.T., Nguyen K.C., Kim N.D., Van T.N., Tuan A.L., Abe K., Flores V., Shiffman M. Autologous Peripheral Blood Stem Cells and &#x3b3;/&#x3b4; T Cells May Improve Immunity in Treating Secondary Bacteremic Infection in HIV Infected Patient. Stem Cell Discov. 2015;5:48. doi: 10.4236/scd.2015.54006.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/scd.2015.54006</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>